ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,554.25
      0.20%
      US Tech 100
      18,971.20
      -0.03%
      Dow Jones
      40,659.76
      0.24%
      Brent Oil
      79.165
      0.00%
      Bitcoin
      59,175.81
      0.51%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE
      6. Aston Martin Np (AMLN)

      7. Aston Martin Np (AMLN) News

      AMLN

      Aston Martin Np (AMLN)

      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:AMLN
      DateTimeSourceHeadlineSymbolCompany
      08/20/200812:55PMEdgar (US Regulatory)Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      08/08/20087:30PMEdgar (US Regulatory)Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      07/31/20084:16PMEdgar (US Regulatory)Amylin Pharmaceuticals Inc - Quarterly Report (10-Q)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      07/22/200811:46AMMarketwiredBellwetherReport.com Analyst Report on BRCD, AMLN, WGOV and PCARNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      07/21/20084:15PMEdgar (US Regulatory)Amylin Pharmaceuticals Inc - Current report filing (8-K)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      07/21/20084:05PMPR Newswire (US)Amylin Pharmaceuticals Reports Second Quarter Financial ResultsNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      07/15/20084:05PMPR Newswire (US)Amylin Pharmaceuticals to Webcast Second Quarter ResultsNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      07/11/200812:33PMEdgar (US Regulatory)Amylin Pharmaceuticals Inc - Prospectus filed pursuant to Rule 424(b)(3) (424B3)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      07/07/20086:55PMEdgar (US Regulatory)Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      07/07/20086:53PMEdgar (US Regulatory)Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      07/07/20086:50PMEdgar (US Regulatory)Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      07/07/20086:46PMEdgar (US Regulatory)Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      07/07/20086:44PMEdgar (US Regulatory)Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      07/07/20086:41PMEdgar (US Regulatory)Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      07/07/20086:39PMEdgar (US Regulatory)Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      07/07/20086:35PMEdgar (US Regulatory)Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      06/19/20084:08PMEdgar (US Regulatory)Amylin Pharmaceuticals Inc - Current report filing (8-K)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      06/11/20089:33AMMarketwiredWall Street News Alert: MEDP Is Wednesday's Stock to Watch! June 11, 2008NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      06/10/20089:05AMMarketwiredStory Stock for Tuesday, June 10, 2008: NPHS Value Added Service!NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      06/09/20088:50PMPR Newswire (US)After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      06/09/20087:30PMPR Newswire (US)Use of Mealtime SYMLIN(R) Compared to Rapid-Acting Insulin for Diabetes Therapy Intensification in Patients With Type 2 DiabetesNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      06/09/200812:56PMMarketwiredBellwetherReport.com Analyst Report on TWTI, HOLX, AMLN and SOLFNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      06/09/200810:40AMPR Newswire (US)Seven Summits Research Releases Comments on MCD, NUE, NEM, CF, and AMLNNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      06/09/20089:10AMMarketwiredStock on the Move for Monday: MEDP! June 9, 2008NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      06/07/20081:00PMPR Newswire (US)Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced INASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      06/07/200812:00PMPR Newswire (US)Type 2 Diabetes Patients Taking Exenatide Once Weekly, a Phase 3 Investigational Diabetes Therapy, Showed Improvements in GlycemNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      06/06/20085:27PMEdgar (US Regulatory)Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      06/06/20085:23PMEdgar (US Regulatory)Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      06/06/20084:11PMEdgar (US Regulatory)Amylin Pharmaceuticals Inc - Securities Registration: Employee Benefit Plan (S-8)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      06/05/20086:30PMPR Newswire (US)Amylin Pharmaceuticals to Present at Goldman Sachs Global Healthcare ConferenceNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
       Showing the most relevant articles for your search:NASDAQ:AMLN